Although cytotoxic CD8+ T cells have been the focus of eliciting an anti-tumor response, it is clear that this response benefits from CD4+ T cell help and it has been shown that cross-priming of CD8+ T cells by DCs requires CD4+ T cell help for effective cytotoxic CD8+ T cell responses (193–195). This evidence concerns the gene CD4 and neoplasm.